secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xilio Therapeutics, Inc. (XLO)
CIK:        0001840233
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001558370-24-012775
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Xilio Therapeutics receives Nasdaq deficiency notice for bid price below $1.00 per share
--------------------------------------------------------------------------------

- Received Nasdaq notice on Sept 10, 2024; common stock bid price below $1.00 for 30 consecutive business days.
- Has 180 calendar days until March 10, 2025 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may transfer to Nasdaq Capital Market for additional 180-day period, subject to other listing standards.
- Company monitoring bid price and evaluating options; no assurance regaining compliance will be achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/0001558370-24-012775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/xlo-20240910x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-012775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer